Sunday 18 October 2026
Export RNA’s income statement to Excel — free account
Atrium Therapeutics, Inc.
RNA
Atrium Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $18.8 million, up 72.1% from fiscal 2024. Revenue growth for three consecutive years.
7.67
0.15
−1.92%
Follow RNA
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | |
|---|---|---|---|---|---|---|---|
Cash and Short Term Investments |
1,696.87 | 1,501.50 | 595.35 | 610.73 | 405.54 | 328.14 | 94.58 |
Total current assets |
1,798.47 | 1,542.29 | 611.31 | 622.94 | 411.14 | 331.68 | 95.68 |
Property, Plant, Equpment (Net) |
23.33 | 12.67 | 8.38 | 6.25 | 4.81 | 1.47 | 0.63 |
Total non-current assets |
23.33 | 12.67 | 8.38 | 6.25 | 4.81 | 1.47 | 0.63 |
Total Assets |
1,958.05 | 1,563.90 | 628.56 | 638.80 | 427.58 | 333.90 | 96.91 |
Total current liabilities |
195.45 | 98.02 | 80.68 | 51.91 | 29.66 | 14.59 | 10.24 |
Long Term Debt (Total) |
— | — | — | — | — | — | 1.77 |
Total non-current liabilities |
— | — | — | — | — | — | 1.77 |
Total liabilities |
269.45 | 138.94 | 127.79 | 60.73 | 46.15 | 27.68 | 27.54 |
Preferred Stock (Total) |
— | — | — | — | — | — | 134.72 |
Retained Earnings |
(1,577.70) | (893.07) | (570.76) | (358.54) | (184.55) | (66.54) | (22.18) |
Common Equity (Total) |
(1,577.70) | (893.07) | (570.76) | (358.54) | (184.55) | (66.54) | (22.18) |
Shareholders Equity (Total) |
1,688.60 | 1,424.96 | 500.76 | 578.08 | 381.43 | 306.22 | 69.36 |
Shareholders Equity and Liabilities (Total) |
1,958.05 | 1,563.90 | 628.56 | 638.80 | 427.58 | 333.90 | 96.91 |
Shareholders Equity (Tangible) |
1,688.60 | 1,424.96 | 500.76 | 578.08 | 381.43 | 306.22 | 69.36 |
Net Debt |
(1,696.87) | (1,501.50) | (595.35) | (610.73) | (405.54) | (328.14) | (92.81) |
Total Debt |
— | — | — | — | — | — | 1.77 |
In millions of $ except per-share values · columns are period end dates